Stock KALO KALLO INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Kallo Inc.

Equities

KALO

US48343P2083

Advanced Medical Equipment & Technology

Delayed OTC Markets
Other stock markets
 09:43:24 2023-12-18 am EST 		5-day change 1st Jan Change
0.0003 USD -.--% Intraday chart for Kallo Inc. -.--% -.--%
2022 Kallo Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
2022 Kallo Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI

Valuation

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Capitalization 1 0.7861 0.1651 27.26 19.11 43.61 97.89
Enterprise Value (EV) 1 1.934 1.133 28.36 20.35 44.97 99.59
P/E ratio -0.25 x -1.04 x -35.7 x -8.09 x -1.21 x -4.36 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -0.8 x -0.17 x - - - -
EV / FCF 3.77 x 0.53 x - - - -
FCF Yield 26.5% 189% - - - -
Price to Book -0.2 x -2.62 x -6.05 x -2.79 x -1.02 x -15.1 x
Nbr of stocks (in thousands) 13,101 16,513 1,135,699 1,151,430 1,147,698 6,356,429
Reference price 2 0.0600 0.0100 0.0240 0.0166 0.0380 0.0154
Announcement Date 11/14/17 4/17/18 12/17/20 1/14/21 3/3/21 6/3/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales - - - - - -
EBITDA 1 -2.422 -6.694 - - - -
EBIT 1 -2.454 -6.726 -0.9112 -2.085 -35.9 -7.971
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -2.999 -7.032 -0.7636 -2.356 -36.06 -8.093
Net income 1 -2.999 -7.032 -0.7636 -2.356 -36.06 -8.093
Net margin - - - - - -
EPS 2 -0.2443 -0.009601 -0.000672 -0.002052 -0.0314 -0.003534
Free Cash Flow 1 0.5123 2.144 - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 11/14/17 4/17/18 12/17/20 1/14/21 3/3/21 6/3/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt 1 1.15 0.97 1.1 1.24 1.36 1.71
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -0.4738 x -0.1445 x - - - -
Free Cash Flow 1 0.51 2.14 - - - -
ROE (net income / shareholders' equity) 102% 167% 17.2% 41.4% 145% 32.8%
ROA (Net income/ Total Assets) -875% -13,780% - - - -
Assets 1 0.3426 0.051 - - - -
Book Value Per Share 2 -0.3000 -0 -0 -0.0100 -0.0400 -0
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 11/14/17 4/17/18 12/17/20 1/14/21 3/3/21 6/3/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Software & Technology Services

1st Jan change Capi.
KALLO INC. Stock Kallo Inc.
-.--% 1.91M
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+5.19% 32.47B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+16.51% 7.45B
SECTRA AB Stock Sectra AB
+23.49% 3.89B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-15.47% 3.17B
OMNICELL, INC. Stock Omnicell, Inc.
-26.77% 1.28B
LUNIT INC. Stock Lunit Inc.
-33.58% 1.09B
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-33.74% 902M
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+1.56% 893M
VERADIGM INC. Stock Veradigm Inc.
-25.64% 857M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. KALO Stock
  4. Financials Kallo Inc.